Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy

Shiri Shulman*, Dafna Goldenberg, Roy Schwartz, Zohar Habot-Wilner, Adiel Barak, Nurit Ehrlich, Anat Loewenstein, Michaella Goldstein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science